NCT02706834View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

June 17, 2016

Study Completion Date

June 17, 2016

Conditions
Dose Finding Study
Interventions
DRUG

TAK-828

TAK-828 oral solution

DRUG

Placebo

TAK-828 placebo-matching oral solution

Trial Locations (2)

Unknown

Baltimore

Austin

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY